Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

GSK FINANCE (NO.3) LIMITED

Company number 12615561

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Mar 2024 SH19 Statement of capital on 26 March 2024
  • USD 1.25
26 Mar 2024 RESOLUTIONS Resolutions
  • RES13 ‐ Cancel share premium 21/03/2024
  • RES06 ‐ Resolution of reduction in issued share capital
26 Mar 2024 CAP-SS Solvency Statement dated 21/03/24
26 Mar 2024 SH20 Statement by Directors
08 Mar 2024 RESOLUTIONS Resolutions
  • RES02 ‐ Resolution of re-registration
08 Mar 2024 MAR Re-registration of Memorandum and Articles
08 Mar 2024 CERT10 Certificate of re-registration from Public Limited Company to Private
08 Mar 2024 RR02 Re-registration from a public company to a private limited company
25 Oct 2023 CS01 Confirmation statement made on 25 October 2023 with no updates
16 Aug 2023 PSC05 Change of details for Glaxo Group Limited as a person with significant control on 6 June 2023
27 Jun 2023 AA Full accounts made up to 31 December 2022
14 Oct 2022 CS01 Confirmation statement made on 14 October 2022 with no updates
15 Jun 2022 AA Full accounts made up to 31 December 2021
25 May 2022 CS01 Confirmation statement made on 20 May 2022 with no updates
20 Jul 2021 CS01 Confirmation statement made on 20 May 2021 with updates
04 Jul 2021 AA Full accounts made up to 31 December 2020
16 Nov 2020 TM01 Termination of appointment of Ciara Martha Lynch as a director on 9 November 2020
17 Jul 2020 SH18 Statement of directors in accordance with reduction of capital following redenomination
17 Jul 2020 RESOLUTIONS Resolutions
  • RES18 ‐ Resolution to reduce share capital on re-denomination
17 Jul 2020 SH15 Reduction of capital following redenomination. Statement of capital on 17 July 2020
  • USD 62,501.25
03 Jul 2020 SH14 Redenomination of shares. Statement of capital 12 June 2020
  • USD 62,870
23 Jun 2020 AA01 Current accounting period shortened from 31 May 2021 to 31 December 2020
22 Jun 2020 SH01 Statement of capital following an allotment of shares on 12 June 2020
  • USD 62,871.2574
10 Jun 2020 CERT8A Commence business and borrow
10 Jun 2020 SH50 Trading certificate for a public company